Cargando…

Association of cancer progression with elevated expression of programmed cell death protein 1 ligand 1 by upper tract urothelial carcinoma and increased tumor-infiltrating lymphocyte density

BACKGROUND: Increased expression of programmed cell death 1 ligand 1 (PD-L1) by tumor cells is thought to be a mechanism through which solid cancers promote immune tolerance. However, the association between PD-L1 expression and the prognosis of upper urinary tract urothelial carcinoma (UTUC) remain...

Descripción completa

Detalles Bibliográficos
Autores principales: Nukui, Akinori, Kamai, Takao, Arai, Kyoko, Kijima, Toshiki, Kobayashi, Minoru, Narimatsu, Takahiro, Kambara, Tsunehito, Yuki, Hideo, Betsunoh, Hironori, Abe, Hideyuki, Fukabori, Yoshitatsu, Yashi, Masahiro, Yoshida, Ken-Ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183489/
https://www.ncbi.nlm.nih.gov/pubmed/32030476
http://dx.doi.org/10.1007/s00262-020-02499-7
_version_ 1783526424126160896
author Nukui, Akinori
Kamai, Takao
Arai, Kyoko
Kijima, Toshiki
Kobayashi, Minoru
Narimatsu, Takahiro
Kambara, Tsunehito
Yuki, Hideo
Betsunoh, Hironori
Abe, Hideyuki
Fukabori, Yoshitatsu
Yashi, Masahiro
Yoshida, Ken-Ichiro
author_facet Nukui, Akinori
Kamai, Takao
Arai, Kyoko
Kijima, Toshiki
Kobayashi, Minoru
Narimatsu, Takahiro
Kambara, Tsunehito
Yuki, Hideo
Betsunoh, Hironori
Abe, Hideyuki
Fukabori, Yoshitatsu
Yashi, Masahiro
Yoshida, Ken-Ichiro
author_sort Nukui, Akinori
collection PubMed
description BACKGROUND: Increased expression of programmed cell death 1 ligand 1 (PD-L1) by tumor cells is thought to be a mechanism through which solid cancers promote immune tolerance. However, the association between PD-L1 expression and the prognosis of upper urinary tract urothelial carcinoma (UTUC) remains unknown. METHODS: We examined immunohistochemical PD-L1 expression and the tumor-infiltrating lymphocyte density (TILD) in 79 patients with UTUC who underwent nephroureterectomy. We classified the tumors into four types based on the combination of PD-L1 expression and TILD, and studied the clinicopathological characteristics of these four tumor types. RESULTS: Elevated expression of PD-L1 by tumor cells and a higher TILD were associated with a worse histological grade, higher pT stage, and higher peripheral blood neutrophil-to-lymphocyte ratio. Elevated expression of PD-L1 by tumor cells, a higher TILD, and type I, III, or IV tumors with elevated expression of either PD-L1 or TILD showed a positive correlation with poorer differentiation and local invasion. These three variables were associated with shorter progression-free survival and overall survival in univariate analysis, but only the latter was an independent determinant according to multivariate analysis. The patients who had type II tumors with lower PD-L1 expression and a lower TILD showed more favorable survival than the other three groups. CONCLUSIONS: These findings suggest that PD-L1 expression and TILs in the tumor microenvironment influence the progression of UTUC. Accordingly, it is important to understand the immunologic characteristics of the tumor microenvironment to develop more effective treatment strategies for this cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00262-020-02499-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7183489
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-71834892020-04-29 Association of cancer progression with elevated expression of programmed cell death protein 1 ligand 1 by upper tract urothelial carcinoma and increased tumor-infiltrating lymphocyte density Nukui, Akinori Kamai, Takao Arai, Kyoko Kijima, Toshiki Kobayashi, Minoru Narimatsu, Takahiro Kambara, Tsunehito Yuki, Hideo Betsunoh, Hironori Abe, Hideyuki Fukabori, Yoshitatsu Yashi, Masahiro Yoshida, Ken-Ichiro Cancer Immunol Immunother Original Article BACKGROUND: Increased expression of programmed cell death 1 ligand 1 (PD-L1) by tumor cells is thought to be a mechanism through which solid cancers promote immune tolerance. However, the association between PD-L1 expression and the prognosis of upper urinary tract urothelial carcinoma (UTUC) remains unknown. METHODS: We examined immunohistochemical PD-L1 expression and the tumor-infiltrating lymphocyte density (TILD) in 79 patients with UTUC who underwent nephroureterectomy. We classified the tumors into four types based on the combination of PD-L1 expression and TILD, and studied the clinicopathological characteristics of these four tumor types. RESULTS: Elevated expression of PD-L1 by tumor cells and a higher TILD were associated with a worse histological grade, higher pT stage, and higher peripheral blood neutrophil-to-lymphocyte ratio. Elevated expression of PD-L1 by tumor cells, a higher TILD, and type I, III, or IV tumors with elevated expression of either PD-L1 or TILD showed a positive correlation with poorer differentiation and local invasion. These three variables were associated with shorter progression-free survival and overall survival in univariate analysis, but only the latter was an independent determinant according to multivariate analysis. The patients who had type II tumors with lower PD-L1 expression and a lower TILD showed more favorable survival than the other three groups. CONCLUSIONS: These findings suggest that PD-L1 expression and TILs in the tumor microenvironment influence the progression of UTUC. Accordingly, it is important to understand the immunologic characteristics of the tumor microenvironment to develop more effective treatment strategies for this cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00262-020-02499-7) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2020-02-06 2020 /pmc/articles/PMC7183489/ /pubmed/32030476 http://dx.doi.org/10.1007/s00262-020-02499-7 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Article
Nukui, Akinori
Kamai, Takao
Arai, Kyoko
Kijima, Toshiki
Kobayashi, Minoru
Narimatsu, Takahiro
Kambara, Tsunehito
Yuki, Hideo
Betsunoh, Hironori
Abe, Hideyuki
Fukabori, Yoshitatsu
Yashi, Masahiro
Yoshida, Ken-Ichiro
Association of cancer progression with elevated expression of programmed cell death protein 1 ligand 1 by upper tract urothelial carcinoma and increased tumor-infiltrating lymphocyte density
title Association of cancer progression with elevated expression of programmed cell death protein 1 ligand 1 by upper tract urothelial carcinoma and increased tumor-infiltrating lymphocyte density
title_full Association of cancer progression with elevated expression of programmed cell death protein 1 ligand 1 by upper tract urothelial carcinoma and increased tumor-infiltrating lymphocyte density
title_fullStr Association of cancer progression with elevated expression of programmed cell death protein 1 ligand 1 by upper tract urothelial carcinoma and increased tumor-infiltrating lymphocyte density
title_full_unstemmed Association of cancer progression with elevated expression of programmed cell death protein 1 ligand 1 by upper tract urothelial carcinoma and increased tumor-infiltrating lymphocyte density
title_short Association of cancer progression with elevated expression of programmed cell death protein 1 ligand 1 by upper tract urothelial carcinoma and increased tumor-infiltrating lymphocyte density
title_sort association of cancer progression with elevated expression of programmed cell death protein 1 ligand 1 by upper tract urothelial carcinoma and increased tumor-infiltrating lymphocyte density
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7183489/
https://www.ncbi.nlm.nih.gov/pubmed/32030476
http://dx.doi.org/10.1007/s00262-020-02499-7
work_keys_str_mv AT nukuiakinori associationofcancerprogressionwithelevatedexpressionofprogrammedcelldeathprotein1ligand1byuppertracturothelialcarcinomaandincreasedtumorinfiltratinglymphocytedensity
AT kamaitakao associationofcancerprogressionwithelevatedexpressionofprogrammedcelldeathprotein1ligand1byuppertracturothelialcarcinomaandincreasedtumorinfiltratinglymphocytedensity
AT araikyoko associationofcancerprogressionwithelevatedexpressionofprogrammedcelldeathprotein1ligand1byuppertracturothelialcarcinomaandincreasedtumorinfiltratinglymphocytedensity
AT kijimatoshiki associationofcancerprogressionwithelevatedexpressionofprogrammedcelldeathprotein1ligand1byuppertracturothelialcarcinomaandincreasedtumorinfiltratinglymphocytedensity
AT kobayashiminoru associationofcancerprogressionwithelevatedexpressionofprogrammedcelldeathprotein1ligand1byuppertracturothelialcarcinomaandincreasedtumorinfiltratinglymphocytedensity
AT narimatsutakahiro associationofcancerprogressionwithelevatedexpressionofprogrammedcelldeathprotein1ligand1byuppertracturothelialcarcinomaandincreasedtumorinfiltratinglymphocytedensity
AT kambaratsunehito associationofcancerprogressionwithelevatedexpressionofprogrammedcelldeathprotein1ligand1byuppertracturothelialcarcinomaandincreasedtumorinfiltratinglymphocytedensity
AT yukihideo associationofcancerprogressionwithelevatedexpressionofprogrammedcelldeathprotein1ligand1byuppertracturothelialcarcinomaandincreasedtumorinfiltratinglymphocytedensity
AT betsunohhironori associationofcancerprogressionwithelevatedexpressionofprogrammedcelldeathprotein1ligand1byuppertracturothelialcarcinomaandincreasedtumorinfiltratinglymphocytedensity
AT abehideyuki associationofcancerprogressionwithelevatedexpressionofprogrammedcelldeathprotein1ligand1byuppertracturothelialcarcinomaandincreasedtumorinfiltratinglymphocytedensity
AT fukaboriyoshitatsu associationofcancerprogressionwithelevatedexpressionofprogrammedcelldeathprotein1ligand1byuppertracturothelialcarcinomaandincreasedtumorinfiltratinglymphocytedensity
AT yashimasahiro associationofcancerprogressionwithelevatedexpressionofprogrammedcelldeathprotein1ligand1byuppertracturothelialcarcinomaandincreasedtumorinfiltratinglymphocytedensity
AT yoshidakenichiro associationofcancerprogressionwithelevatedexpressionofprogrammedcelldeathprotein1ligand1byuppertracturothelialcarcinomaandincreasedtumorinfiltratinglymphocytedensity